Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia

Durrington, 2003, Dyslipidaemia, Lancet, 362, 717, 10.1016/S0140-6736(03)14234-1 LaRosa, 2003, Understanding risk in hypercholesterolemia, Clin. Cardiol., 26, 13 LaRosa, 1999, Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials, JAMA, 282, 2340, 10.1001/jama.282.24.2340 Law, 2003, Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis, BMJ, 326, 1423, 10.1136/bmj.326.7404.1423 Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults, 2001, Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Smilde, 2001, Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial, Lancet, 357, 577, 10.1016/S0140-6736(00)04053-8 2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 de Backer, 2003, European guidelines on cardiovascular disease prevention in clinical practice, Eur. J. Cardiovasc. Prev. Rehabil., 10, S1, 10.1097/00149831-200312001-00001 Stone, 2002, Combination therapy: its rationale and the role of ezetimibe, Eur. Heart J., 4, J19, 10.1016/S1520-765X(02)90078-7 van Heek, 2002, Pharmacology of ezetimibe, Eur. Heart J., 4, J5, 10.1016/S1520-765X(02)90076-3 Davidson, 2002, Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia, J. Am. Coll. Cardiol., 40, 2125, 10.1016/S0735-1097(02)02610-4 Kerzner, 2003, Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia, Am. J. Cardiol., 91, 418, 10.1016/S0002-9149(02)03236-8 Ballantyne, 2003, Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial, Circulation, 107, 2409, 10.1161/01.CIR.0000068312.21969.C8 Melani, 2003, Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial, Eur. Heart J., 24, 717, 10.1016/S0195-668X(02)00803-5 Gagne, 2002, Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia, Am. J. Cardiol., 90, 1084, 10.1016/S0002-9149(02)02774-1 Sager, 2003, Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein, Am. J. Cardiol., 92, 1414, 10.1016/j.amjcard.2003.08.048 Mack, 2000, Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography, Atherosclerosis, 150, 371, 10.1016/S0021-9150(99)00383-4 Cheng, 2002, A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors, Cardiovasc. Res., 54, 528, 10.1016/S0008-6363(01)00551-X Hodis, 1998, The role of carotid arterial intima-media thickness in predicting clinical coronary events, Ann. Intern. Med., 128, 262, 10.7326/0003-4819-128-4-199802150-00002 Crouse, 1995, Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II), Am. J. Cardiol., 75, 455, 10.1016/S0002-9149(99)80580-3 de Groot, 1998, B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS), J. Am. Coll. Cardiol., 31, 1561, 10.1016/S0735-1097(98)00170-3 Kroon, 1996, Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease, Ann. Intern. Med., 125, 945, 10.7326/0003-4819-125-12-199612150-00001 Kroon, 1996, LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis, Circulation, 93, 1826, 10.1161/01.CIR.93.10.1826 Salonen, 1995, Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries, Circulation, 92, 1758, 10.1161/01.CIR.92.7.1758 Marks, 2003, A review on the diagnosis, natural history, and treatment of familial hypercholesterolemia, Atherosclerosis, 168, 1, 10.1016/S0021-9150(02)00330-1 Nolting, 2003, Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin, Arch. Intern. Med., 163, 1837, 10.1001/archinte.163.15.1837 Wendelhag, 1996, On quantifying plaque size and intima-media thickness in carotid and femoral arteries. Comments on results from a prospective ultrasound study in patients with familial hypercholesterolemia, Arterioscler. Thromb. Vasc. Biol., 16, 843, 10.1161/01.ATV.16.7.843 Wittekoek, 1999, Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease, Atherosclerosis, 146, 271, 10.1016/S0021-9150(99)00147-1